selected scholarly activity
-
chapters
- Critical Issues in Osteoporosis Management. 37-50. 2021
- Metabolic Bone Disease in Gastrointestinal Disorders. 240-257. 2019
- 202 Glucocorticoid-induced osteoporosis. 1674-1679. 2015
- Glucocorticoid-induced osteoporosis. 1674-1679. 2015
- Metabolic Bone Disease. 279-304. 2015
-
conferences
- Impact of the COVID-19 pandemic on patients with rheumatoid arthritis: data from the Ontario Best Practices Research Initiative (OBRI). Rheumatology Advances in Practice. 2023
- Medical Cannabis Use in Patients Attending Rheumatology Clinics in Ontario. Journal of Rheumatology. 1118-1118. 2021
- Comparison between Patients with Spondyloarthritis Managed in Community Based Care Settings to those Managed in Tertiary Research Setting in Ontario: An OBRI-SPARCC Study. Journal of Rheumatology. 1060-1061. 2020
- Rheumatologist Survey on Medical Cannabis: Results from the Ontario Best Practices Research Initiative: (OBRI). Journal of Rheumatology. 1091-1092. 2020
- Evaluation of the Fracture Liaison Service within the Canadian Healthcare Setting. Journal of Osteoporosis. 2020
- Tool for estimating risk of Atypical Femur Fractures. Journal of Bone and Mineral Research. 288-288. 2019
- Longitudinal Changes in Relative Market Share Proportions of Biologic, and Targeted Synthetic, Disease-Modifying Anti-Rheumatic Drugs (DMARDs) for Treatment of Rheumatoid Arthritis: Results from the Ontario Best Practices Research Initiative (OBRI). Journal of Rheumatology. 821-821. 2019
- THU0163 A DESCRIPTIVE ANALYSIS OF LONGITUDINAL CHANGES IN RELATIVE MARKET SHARE PROPORTIONS OF BIOLOGIC AND TARGETED SYNTHETIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS FOR TREATMENT OF RHEUMATOID ARTHRITIS: DATA FROM THE OBRI DATABASE. Annals of the Rheumatic Diseases. 355-355. 2019
- Current Factors Associated with Insufficient Vitamin D Status in Patients with Osteoporosis. Arthritis & Rheumatology. 2018
- Longitudinal Changes in Relative Market Share Proportions of Biologic and Targeted Synthetic Disease-Modifying Anti-Rheumatic Drugs for Treatment of Rheumatoid Arthritis: Descriptive Data from the Ontario Best-Practice Research Initiative Database. Arthritis & Rheumatology. 2018
- Efficacy of Janus Kinase (JAK) Inhibitors in Rheumatoid Arthritis: A Meta-analysis and Systematic Review. Journal of Rheumatology. 991-991. 2018
- Occurrence of Serious Infection in Patients with Rheumatoid Arthritis Treated with Biologics and Denosumab Observed in a Clinical Setting. Journal of Rheumatology. 170-176. 2018
- Frailty and Risk of Fractures in Patients with Rheumatoid Arthritis: Data from the Ontario Best Practices Research Initiative (OBRI). Bone. 2017
- Impact of Concomitant Use of Disease Modifying Antirheumatic Drugs and Methotrexate Administration Route on Durability of Biologic Treatment: Results from the Ontario Best Practice Research Initiative (OBRI) Cohort. Journal of Rheumatology. 873-873. 2017
- Magnetic Resonance Imaging Measures of Disease Activity in Rheumatoid Arthritis Patients Treated with Multiple Regimens of DMARD Therapy. Journal of Rheumatology. 885-886. 2017
- The Rationale for Using a Composite Score when Designing Future Randomized Controlled Trials in the Post-menopausal Osteoporisis Population: A Systematic Review. Journal of Rheumatology. 943-944. 2017
- Anatomical Patterns Suggest the Involvement of Biomechanical Stress in the Pathogenesis of Erosions in Rheumatoid Arthritis. Arthritis & Rheumatology. 2016
- Magnetic Resonance Imaging Measures of Disease Activity in Rheumatoid Arthritis Patients Treated with Multiple Regimens of DMARD Therapy. Arthritis & Rheumatology. 2016
- What Is the Relationship Between Early Metacarpophalangeal Erosions on MRI and Joint Pain in Rheumatoid Arthritis?. Arthritis & Rheumatology. 2016
- A Longitudinal Pilot Study Investigating Changes in Metacarpophalangeal Erosive Damage and Functional Ability in Patients with Rheumatoid Arthritis Using Magnetic Resonance Imaging and Computerized Segmentation. Journal of Rheumatology. 1200-1201. 2016
- FRI0159 Persistence with Biologic Monotherapy in Comparison with Combination Therapy with Disease-Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis; Results from An Ontario Rheumatoid Arthritis Cohort. Annals of the Rheumatic Diseases. 486.2-487. 2016
- FRI0221 Occurrence of Serious Infection in Patients with Rheumatoid Arthritis Treated with Biologics and Denosumab Observed in A Clinical Setting:. Annals of the Rheumatic Diseases. 512.2-512. 2016
- Persistence with Biologic Monotherapy in Comparison with Combination Therapy with Disease-Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis; Results from a Rheumatoid Arthritis Cohort. Journal of Rheumatology. 1245-1246. 2016
- Ribbing's Disease Compared to Intramedullary Osteosclerosis: A Case Presentation. Journal of Rheumatology. 1168-1168. 2016
- Understanding Erosions Inside-Out: Erosion Depth Predicts Bone Repair over 2 Years in Rheumatoid Arthritis. Journal of Rheumatology. 1152-1153. 2016
- Does Computerized Segmentation of Early Erosions on Magnetic Resonance Imaging Predict Functional Ability in Rheumatoid Arthritis?. Arthritis & Rheumatology. 2015
- Occurrence of Serious Infection in Patients with Rheumatoid Arthritis Treated with Biologics and Denosumab Observed in a Clinical Setting. Arthritis & Rheumatology. 2015
- Persistence with Biologic Monotherapy in Comparison with Combination Therapy with Disease-Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis; Results from a Rheumatoid Arthritis Cohort. Arthritis & Rheumatology. 2015
- Early Erosions in Rheumatoid Arthritis (EERA) Software Reliably Measures Erosive Damage on MRI in the Metacarpophalangeal Joints of Rheumatoid Arthritis Patients. Journal of Rheumatology. 1320-1321. 2015
- Improvements in Bone Mineral Density and Health Related Quality of Life Maintained in Patients Treated with Teriparatide. Journal of Rheumatology. 1288-1288. 2015
- Survey of Patient Perspectives on the Introduction of Subsequent Entry Biologics in Canada. Journal of Rheumatology. 1336-1337. 2015
- Assessing the Validity and Reliability of a Novel MRI Semi-Automated Algorithm for Quantifying Bone Loss in the Hand.. Arthritis & Rheumatology. S515-S515. 2014
- Bone Erosions in Patients with RA: Exploring the Impact of the Anatomy of Interest on the Relationship Between MRI and X-Ray Erosion Detection.. Arthritis & Rheumatology. S628-S629. 2014
- How Does Non-Compliance to Prolia® (DENOSUMAB) Impact the Change in Bone Mineral Density (BMD) in Osteoporotic Patients?. Arthritis & Rheumatology. S982-S983. 2014
- Patient Perspectives on the Introduction of Subsequent Entry Biologics in Canada.. Arthritis & Rheumatology. S663-S663. 2014
- The Efficacy and Safety of Biological Disease Modifying Anti-Rheumatic Drugs and Apremilast in the Treatment of Psoriatic Arthritis: A Systematic Review and Meta-Analysis. Arthritis & Rheumatology. S692-S692. 2014
- Validation of Snapshot, a Rheumatoid Arthritis Assessment Tool, Against CDAI, DAS28 (ESR), and DAS28 (CRP) in Canadian Patients with Rheumatoid Arthritis. Arthritis & Rheumatology. S156-S156. 2014
- How does Non-Compliance to Prolia (R) (Denosumab) Affect the Change in Bone Mineral Density (BMD)?. Journal of Rheumatology. 1541-1542. 2014
- AB0221 Does Etanercept Maintain Its Efficacy in the Elderly Population. A Single Center Retrospective Analysis. Annals of the Rheumatic Diseases. 876.3-877. 2014
- SAT0458 How Does Non-Compliance to Prolia ® (DENOSUMAB) Affect the Change in Bone Mineral Density (BMD)?. Annals of the Rheumatic Diseases. 759.2-760. 2014
- THU0153 Pregnancy Outcomes in Women Exposed to the Tumor Necrosis Factor Inhibitor, Golimumab. Annals of the Rheumatic Diseases. 232.2-233. 2014
- Long-term Improvements in Bone Mineral Density and Health Related Quality of Life in Osteoporosis Patients Treated with Teriparatide.. Journal of Bone and Mineral Research. S476-S476. 2014
- Effectiveness Of Etanercept In Elderly Patients With Rheumatoid Arthritis: A Single Center Retrospective Study. Arthritis and Rheumatism. S627-S627. 2013
- Team Managed Care From a Patient's Perspective: A Study Of Biological Patients At a Canadian Centre. Arthritis and Rheumatism. S78-S79. 2013
- A Retrospective Study to Evaluate the Effectiveness, Drug Survival, and Safety of Golimumab in Rheumatoid Arthritis Patients in Canadian Rheumatology Practice. Journal of Rheumatology. 984-984. 2013
- A Retrospective Study to Evaluate the Effectiveness, Safety and Drug Survival of Tocilizumab in Rheumatoid Arthritis Patients in a Single Hamilton Practice. Journal of Rheumatology. 1003-1004. 2013
- A Retrospective Study to Evaluate the Safety, Efficacy, and Drug Survival of Rituximab in Rheumatoid Arthritis Patients in a Single Canadian Practice. Journal of Rheumatology. 1003-1003. 2013
- Care Gap in the Treatment of Patients with High Risk for Fractures in a Single Canadian Academic Center. Journal of Rheumatology. 985-985. 2013
- Efficacy of Denosumab after Implementation of Charlton Patient Advocacy Program. Journal of Rheumatology. 1003-1003. 2013
- Golimumab Start-Stop: Drug Discontinuation due to Financial Constraints; Experience from a Single Hamilton Center. Journal of Rheumatology. 984-985. 2013
- Reliability of the Early Erosions in Rheumatoid Arthritis Software when Quantifying Bone Loss. Journal of Rheumatology. 1020-1020. 2013
- TEAM-Managed Care of Biological Patients at a Canadian Centre. Journal of Rheumatology. 1004-1004. 2013
- Validation of SNAPSHOT (c) (TM) As a Rheumatoid Arthritis Clinical Assessment Tool. Journal of Rheumatology. 1021-1022. 2013
- Vitamin D in Obesity (VIDeO): Assessing Vitamin D Deficiency in the Bariatric Population, a Quality Assurance Initiative. Journal of Rheumatology. 1020-1020. 2013
- Care Gap in the Treatment of Patients with High Risk for Fractures in a Single Canadian Academic Center. Arthritis and Rheumatism. S839-S839. 2012
- Reliability of the Early Erosions in Rheumatoid Arthritis Software When Quantifying Bone Loss.. Arthritis and Rheumatism. S441-S441. 2012
- Vitamin D in Obesity (VIDeO): Assessing Vitamin D Deficiency in the Bariatric Population. Arthritis and Rheumatism. S439-S439. 2011
- Assessing the Practice and Attitudes of Nursing Staff in Long Term Care (LTC) Facilities Related to Osteoporosis Awareness, Management and Fracture Prevention. Journal of Rheumatology. 1335-1336. 2010
- Resolution of Osteonecrosis of the Jaw after Teriparatide [Recombinant Human PTH-(1-34)] Therapy. Journal of Rheumatology. 1296-1296. 2010
- Teriparatide improves osteoporosis related fracture pain. Bone. S22-S22. 2007
-
journal articles
- Hip fracture rate and osteoporosis treatment in Ontario: A population-based retrospective cohort study. Archives of Osteoporosis. 19:53. 2024
- Risk Factors and Clinical Outcomes Associated With Sarcopenia in Rheumatoid Arthritis. Journal of Clinical Rheumatology. 30:18-25. 2024
- Factors affecting the discrepancy between patient and physician global assessment in early rheumatoid arthritis: The Ontario Best Practices Research Initiative.. Clinical and Experimental Rheumatology. 41:2249-2256. 2023
- Effectiveness and Safety of Tofacitinib in Canadian Patients With Rheumatoid Arthritis: Primary Results From a Prospective Observational Study. Arthritis Care and Research. 75:240-251. 2023
- Medical cannabis use by rheumatology patients in routine clinical care: results from The Ontario Best Practices Research Initiative. Clinical and Experimental Rheumatology. 41:118-125. 2023
- Physician- and Patient-reported Effectiveness Are Similar for Tofacitinib and TNFi in Rheumatoid Arthritis: Data From a Rheumatoid Arthritis Registry. Journal of Rheumatology. 49:447-453. 2022
- Disease activity trajectories for early and established rheumatoid arthritis: Real-world data from a rheumatoid arthritis cohort. PLoS ONE. 17:e0274264-e0274264. 2022
- Heterogeneity in Patient Characteristics and Differences in Treatment Across 4 Canadian Rheumatoid Arthritis Cohorts. Journal of Rheumatology. 49:16-25. 2022
- Changes in Market Share of Biologic and Targeted Synthetic Disease-Modifying Anti-Rheumatic Drugs for Treatment of Rheumatoid Arthritis: Results from the Ontario Best-Practice Research Initiative Database. Current Rheumatology Reviews. 17:349-359. 2021
- Understanding and Managing Corticosteroid-Induced Osteoporosis. Open Access Rheumatology: Research and Reviews. Volume 13:177-190. 2021
- Relationship Between Obesity and Risk of Major Osteoporotic Fracture in Postmenopausal Women: Taking Frailty Into Consideration. Journal of Bone and Mineral Research. 35:2355-2362. 2020
- Romosozumab in the Treatment of Osteoporosis. Immunotherapy. 12:965-981. 2020
- Comparison of the clinical effectiveness and safety between the use of denosumab vs bisphosphonates in renal transplant patients. Osteoporosis International. 31:973-980. 2020
- Correction to: Comparison of the clinical effectiveness and safety between the use of denosumab vs bisphosphonates in renal transplant patients. Osteoporosis International. 31:981-981. 2020
- Evaluation of the Fracture Liaison Service within the Canadian Healthcare Setting. Journal of Osteoporosis. 2020:1-6. 2020
- Determining known-group validity and test-retest reliability in the PEQ (personalized exercise questionnaire). BMC Musculoskeletal Disorders. 20:373. 2019
- Frailty and risk of osteoporotic fractures in patients with rheumatoid arthritis: Data from the Ontario Best Practices Research Initiative. Bone. 127:129-134. 2019
- Effect of Concomitant Disease-modifying Antirheumatic Drugs and Methotrexate Administration Route on Biologic Treatment Durability in Rheumatoid Arthritis: OBRI Cohort Results. Journal of Rheumatology. 46:874-886. 2019
- Complex interventions can increase osteoporosis investigations and treatment: a systematic review and meta-analysis. Osteoporosis International. 29:5-17. 2018
- Modifying the Phenotypic Frailty Model in Predicting Risk of Major Osteoporotic Fracture in the Elderly. Journal of the American Medical Directors Association. 18:414-419. 2017
- A Comparison of CAROC and FRAX in Patients with Fragility Fracture. Journal of Rheumatology. 43:1456-1457. 2016
- The Effects of Noncompliance to Prolia (Denosumab) on the Changes in Bone Mineral Density: A Retrospective Review. Journal of Osteoporosis. 2016:1-5. 2016
- The relationship between long-term proton pump inhibitor therapy and skeletal frailty. Endocrine. 49:606-610. 2015
- The Tissue-Selective Estrogen Complex: A Review of Current Evidence. Rheumatology and Therapy. 2:47-58. 2015
- Systemic Lupus Erythematosus, Osteoporosis, and Fractures. Journal of Rheumatology. 41:1913-1915. 2014
- The Current Practice of Screening, Prevention, and Treatment of Androgen-Deprivation-Therapy Induced Osteoporosis in Patients with Prostate Cancer. Journal of Oncology. 2012:1-7. 2012
- What are the beliefs, attitudes and practices of front-line staff in long-term care (LTC) facilities related to osteoporosis awareness, management and fracture prevention?. BMC Geriatrics. 10:73. 2010
- Role of teriparatide in treatment of glucocorticoid-induced osteoporosis. Therapeutics and Clinical Risk Management. Volume 6:497-503. 2010
- Dr. Adachi and Dr. Lau reply. Journal of Rheumatology. 37:676.1-676. 2010
- Resolution of Osteonecrosis of the Jaw After Teriparatide [Recombinant Human PTH-(1-34)] Therapy. Journal of Rheumatology. 36:1835-1837. 2009
- Improvement in health-related quality of life in osteoporosis patients treated with teriparatide. BMC Musculoskeletal Disorders. 9:151. 2008
- Thiazolidinediones and Their Effect on Bone Metabolism: A Review. Canadian Journal of Diabetes. 31:378-383. 2007